Generating Real‐World Evidence From the Excellence Network in Rheumatology
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.70067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Timothy Beukelman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Advancing Science, Technology, Education, and Research (FASTER), Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Rheumatology, Electronic Health Records. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Purpose
The Excellence Network in RheumatoloGY (ENRGY) was founded in 2021 and encompasses data from more than 700 private practice rheumatology providers throughout the United States, forming a practice‐based research network (PBRN).
Methods
Electronic health record (EHR) data from participating practices are aggregated, including structured data (e.g., clinical assessments) and unstructured data from two different EHR platforms. Targeted data quality efforts ensure capture of high‐quality clinical data and reduce missingness. ENRGY network membership also provides participating sites access to technology services that enhance patient care. Centralized ethics approval and pre‐existing legal agreements along with electronic tools to curate data and contact eligible study participants improves efficiency of multi‐center prospective studies.
Results
The ENRGY data warehouse includes linked administrative claims data for commercial and government‐provided insurance (31% of patients linked to commercial claims) and patient‐generated health data from both in‐office and out‐of‐office settings via a smartphone app as well as biosensor data. ENRGY data and infrastructure can be employed to identify the highest yield sites for prospective studies; identify patients meeting study eligibility criteria; pre‐screen individual patient's willingness to participate in specific studies; centralize study data monitoring; and assist in the conduct of prospective studies.
Conclusion
ENRGY data have been used to generate a growing number of scientific publications and may serve as a model for PBRNs in other specialties seeking to harness the potential of data linkages, patient‐generated data capture, and centralized study infrastructure for observational and interventional research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Foundation for Advancing Science, Technology, Education, and Research (FASTER), Birmingham, Alabama, USA.
- Illumination Health, Hoover, Alabama, USA.
- Global Healthy Living Foundation (GHLF), Upper Nyack, New York, USA.
- University of Pennsylvania School of Medicine, Philadelphia, USA.
- American Arthritis and Rheumatology Associates (AARA), Boca Raton, USA.
- University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Timothy Beukelman
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Beukelman, T., Mudano, A., Stewart, P., Venkatachalam, S., Xie, F., George, M., Busch, H., Reddy, P., Saag, K. G., Su, Y., & Curtis, J. R. (2024). Generating Real‐World Evidence From the Excellence Network in Rheumatology. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70067
Vancouver
Beukelman T, Mudano A, Stewart P, Venkatachalam S, Xie F, George M, et al. Generating Real‐World Evidence From the Excellence Network in Rheumatology. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70067
BibTeX
@article{Beukelman2024,
author = {Beukelman, Timothy and Mudano, Amy and Stewart, Patrick and Venkatachalam, Shilpa and Xie, Fenglong and George, Michael and Busch, Howard and Reddy, Priya and Saag, Kenneth G and Su, Yujie and Curtis, Jeffrey R},
title = {Generating Real‐World Evidence From the Excellence Network in Rheumatology},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.70067}
}
EUVIMED